As a Mod on the iHub board as well I can see who is
As a Mod on the iHub board as well I can see who is deleting posts and it is Lurkin. Sometimes I reinstate them a few times and he undoes them again - a complete waste of my time now that the iHub $INCC board is effectively being boycotted by most serious traders - as happened in 2015>3Q 2016. When there are absolutely no grounds for the deletion, I file a TOS violation - sometimes they get restored.
It must be a sad life for vendetta bashers to spend the whole time for years on end - including weekends and late nights / early mornings - trying to damage the reputation of CEOs and the interests of legitimate shareholders in an attempt to make others lose as much as they have.
Conspiracy to affect the price of a security is a felony and there is obvious collusion between the bashers that plant repeat nonsense posts so that one or more of the others can reply to it in the belief that if you repeat the same nonsense over and over again - and use upper case letters - that the naive will believe it. Another problem with iHub is that one Mod is not supposed to delete items put up by another - which is the only reason all the outdated news and irrelevant so-called "fail" list is still up.
Although I have collected plenty of evidence of their activities, the SEC really isn't interested in investigating unless a lot of people have lost $Ms in an obvious manipulation which of course is not the case with $INCC. On the contrary, there is no excuse for having lost money on $INCC because the activities of the bashers have offered huge opportunities on a repeat basis for adding large amounts at bargain prices in the .0002>.0015 for future developments. Those that have been patient from 3Q 2014 to the runs in 3Q 2016 and early 2017 have done very well indeed with opportunities to add now for developments in the future that are known to be upcoming - particularly the name change and ticker change that will remove some of the "baggage" created by bashers.
1
Tersis Technologies, Inc. (TERS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding the Textile Recycling Market Growth The global textile recycling market is experiencing significant transformation fueled by a growing emphasis on sustainability and environmental awareness. With a projected value reaching approximately $7.26 billion, and an expected annual growth rate of 4.9%, the industry reflects changing consumer preferences and global...
Continue Reading
Mobile Infrastructure Corporation Closes Major Financing Round Mobile Infrastructure Corporation (NASDAQ: BEEP) has successfully completed a significant $100 million Asset-Backed Securitization (ABS) focused on enhancing its financial structure and opening avenues for future growth. This landmark achievement is a testament to the forward-thinking strategies and the robust...
Continue Reading
Global Kiosk Market Overview As we delve into the dynamic landscape of the kiosk market, projections indicate an impressive growth trajectory. The global kiosk market is set to expand significantly, with expectations to reach a remarkable USD 62.2 billion by the end of the forecast period. The anticipated compound annual growth rate (CAGR) of 12.74% from 2024 to 2031...
Continue Reading
Wallbridge Mining Launches Phase 2 Drilling at Martiniere Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) is excited to announce that it has commenced its second phase of drilling at the fully owned Martiniere gold project. This new drilling campaign aims to build on the positive results from its Phase 1 drilling campaign. Continuing Exploration Efforts The...
Continue Reading
Spirovant Sciences Launches Groundbreaking Gene Therapy Trial Spirovant Sciences, a pioneering clinical-stage gene therapy company, has taken a significant step forward in the battle against cystic fibrosis with the administration of the first dose in their SAAVe Phase 1/2 clinical trial of SP-101 combined with a unique augmenter. The Innovative SP-101 Treatment SP-101 is...
Continue Reading